COVID-19

The coronavirus disease 2019 (COVID-19) is a severe acute respiratory syndrome caused by the infection of the SARS-CoV-2 virus. In March 2020 the World Health Organization (WHO) declared the outbreak of this disease as a pandemic. In the scientific field, it is known that the susceptibility to certain viral infections is influenced by genetic factors specific to each individual. With this background, it could be suggested that it is possible that the genome of each person plays an important role in the response to the coronavirus and in this way it is possible to predict who is at greater risk of an infection. The interest in answering this question has prompted various initiatives that seek to analyze the genome of people who have tested positive for COVID-19 and look for differences between those who have developed more serious symptoms and those who have not shown any signs of infection or what have done mildly.

Fernando Suárez

Clinical Geneticist, Director of Institute for Human Genetics, Pontificia Universidad Javeriana. 

Adriana Rojas

Biochemist - MSc (Universidad de los Andes) - PhD (Universidad de Chile) - Professor at Instituto de Genética Humana - Pontificia Universidad Javeriana

Nancy Gélvez

Bacteriologist Master of Science with an Emphasis in Genetics Associate professor

Paola Ayala

Bacteriologist Master of Biological Sciences with an Emphasis in Human Genetics Assistant teacher

PROFESSIONALS ASSOCIATED WITH THE PROJECT

Analysis of the allelic variation and gene expression of the ACE2 receptor in a population of the Hospital Universitario San Ignacio exposed to SARS-Cov-2.

STUDENTS

Our research group is interested in evaluating the presence of allelic variants in the ACE2 gene in the Colombian population and determining whether the presence of these variants is associated with susceptibility to infection and / or clinical outcome.

Daniel M. González

Bacteriologist - Master's Degree in Biological Sciences. Analysis of the allelic variation and gene expression of the ACE2 receptor in a population of the Hospital Universitario San Ignacio exposed to SARS-Cov-2.